Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer

Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer

Abstract Background Bromodomain-containing protein (BRD) play a pivotal role in the development and progression of malignant tumours. This study aims to identify prognostic genes linked to BRD-related genes (BRDRGs) in patients with triple-negative breast cancer (TNBC) and to construct a novel progn...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wei Chen, Yushuai Yu, Chenxi Wang, Zirong Jiang, Xiewei Huang, Yidan Lin, Hongjing Han, Qing Wang, Hui Zhang
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Cancer Cell International
Subjects:	Triple-negative breast cancer Bromodomain-containing protein Immune microenvironment Prognosis
Online Access:	https://doi.org/10.1186/s12935-025-03648-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tumor microenvironment and immunotherapy for triple-negative breast cancer
by: Zijie Guo, et al.
Published: (2024-12-01)

Investigation of survival and prognostic factors in triple negative molecular subtype male breast cancer patients: A population-based study
by: Ahmet Necati Sanli, et al.
Published: (2024-04-01)

Functionalized biomimetic nanoparticles loaded with salvianolic acid B for synergistic targeted triple-negative breast cancer treatment
by: Nuo Cheng, et al.
Published: (2025-02-01)

RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel
by: Jialin Yuan, et al.
Published: (2025-01-01)

Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
by: Chang Cheng, et al.
Published: (2025-01-01)

Multiomics analysis reveals the involvement of NET1 in tumour immune regulation and malignant progression
by: Jian Pang, et al.
Published: (2025-01-01)

Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker
by: Umay Kiraz, et al.
Published: (2025-01-01)

Triple-negative breast cancer patients treated with subcutaneous mastectomy with immediate reconstruction: single institution experience
by: Artur Bocian, et al.
Published: (2024-12-01)

Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
by: Xin Liu, et al.
Published: (2024-12-01)

Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk
by: Xinyu Ren, et al.
Published: (2025-04-01)

Deep Learning and Radiomics in Triple-Negative Breast Cancer: Predicting Long-Term Prognosis and Clinical Outcomes
by: Cheng C, et al.
Published: (2025-01-01)

Classifications of triple-negative breast cancer: insights and current therapeutic approaches
by: Ziqi Chen, et al.
Published: (2025-02-01)

Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment
by: Tangyi Wang, et al.
Published: (2025-01-01)

The value of inflammation-related indicators in chemotherapy efficacy and disease-free survival of triple-negative breast cancer
by: Jie Zhu, et al.
Published: (2025-02-01)

Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma: Relationship With Prognostic Factors and Response to Neoadjuvant Chemotherapy
by: Özgen Arslan Solmaz, et al.
Published: (2025-01-01)

Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function
by: Annat Raiter, et al.
Published: (2025-02-01)

Development of a prognostic model based on four genes related to exhausted CD8+ T cell in triple-negative breast cancer patients: a comprehensive analysis integrating scRNA-seq and bulk RNA-seq
by: Yulin Shi, et al.
Published: (2025-02-01)

The analysis of gene co-expression network and immune infiltration revealed biomarkers between triple-negative and non-triple negative breast cancer
by: Yao Yi, et al.
Published: (2025-01-01)

The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
by: Huayan Gu, et al.
Published: (2025-02-01)

B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer
by: Nicole J. Toney, et al.
Published: (2025-01-01)

Prognostic factors in hereditary breast cancer: A review
by: Ziske Maritska, et al.
Published: (2024-08-01)

Comparative survival outcomes of neoadjuvant and adjuvant therapy in patients with T1c, node-negative, triple-negative breast cancer: A population-based analysis
by: Yi-Zi Zheng, et al.
Published: (2025-02-01)

Exploring the Prognostic Role of Trop-2, CD47, and CD163 Expression Levels on Survival Outcomes in Patients with Triple-Negative Breast Cancer
by: Ramazan Oguz Yüceer, et al.
Published: (2025-01-01)

Giant triple negative pregnancy-associated breast cancer (PABC) in a young woman: From diagnosis to therapy step by step: A case report
by: Micol Bottalico, et al.
Published: (2025-03-01)

Network Pharmacology, Molecular Docking, and Molecular Dynamics Analysis of Honokiol against Triple-negative Breast Cancer
by: Hassan H. Alhassan
Published: (2024-12-01)

Interleukin-12 Inhibits Tumor Growth and Metastasis Promoted by Tumor-Associated Mesenchymal Stem Cells in Triple-Negative Breast Cancer
by: Babak Jahangiri, et al.
Published: (2024-09-01)

The microenvironment cell index is a novel indicator for the prognosis and therapeutic regimen selection of cancers
by: Xian-Yan Yang, et al.
Published: (2025-01-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells
by: Sima Kianpour Rad, et al.
Published: (2025-01-01)

CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line
by: Amr A. Waly, et al.
Published: (2025-01-01)

Mechanistic insights into pachymic acid’s action on triple-negative breast Cancer through TOP2A targeting
by: Ming Liu, et al.
Published: (2025-01-01)

Function of vasohibin-2 and the mechanism of alternative splicing in triple-negative breast cancer
by: WANG Wei, et al.
Published: (2024-12-01)

A computational and structural approach to identify malignant non-synonymous FOXM1 single nucleotide polymorphisms in triple-negative breast cancer
by: Prarthana Chatterjee, et al.
Published: (2025-01-01)

The potential benefits of radiotherapy in elderly patients with early-stage triple-negative breast cancer
by: Zheng Xu, et al.
Published: (2025-01-01)

A preliminary study on the prognostic significance of cysteine-rich EGF ligand domain 2 protein (CRELD2) in patients with triple negative breast cancer
by: Mehmet Zahid Kocak, et al.
Published: (2025-01-01)

Ethanolic Extract of <i>Averrhoa carambola</i> Leaf Has an Anticancer Activity on Triple-Negative Breast Cancer Cells: An In Vitro Study
by: Oscar F. Beas-Guzmán, et al.
Published: (2024-12-01)

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
by: Wen-yu Cai, et al.
Published: (2025-02-01)

Telomerase and mitochondria inhibition promote apoptosis and TET2 and ANMT3a expression in triple negative breast cancer cell lines
by: Zeinab Mazloumi, et al.
Published: (2024-07-01)

Predictive markers of rapid disease progression and chemotherapy resistance in triple-negative breast cancer patients following postoperative adjuvant therapy
by: Tao Ma, et al.
Published: (2025-01-01)

SHP2 promotes the epithelial-mesenchymal transition in triple negative breast cancer cells by regulating β-catenin
by: Shihan Qian, et al.
Published: (2025-01-01)